Photoimmunotherapy
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
To Conquer Cancer with Light: Rakuten Medical Accelerates Global Trials on First-in-Class Next-Gen Treatment
2025-08-12
Rakuten Medical Partners with OEP Group to Expand in Asia, Promoting Photoimmunotherapy for Recurrent Head and Neck Cancer
2025-06-26
LATEST
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California







